glp 1 dementia prevention Role of glucagon-like peptide-1 receptor agonists in Alzheimer's disease and Parkinson's disease | Journal of Biomedical Science Weight Loss Drug Dementia: Could

(PubMed) Hoffer LJ

Together, these findings indicate that GSH catabolism by GGTs is an important source of amino acids, including cysteine

81 This treatment also ameliorates glomerular hyperfiltration, improves endothelial function and survival, reduces the production of reactive oxygen species, C-reactive protein and interleukin 6, increases vasodilator levels, and decreases the levels of vasoconstrictors

No one has tested whether the effects are additive, synergistic, or negligible when combined

In this group of patients, following treatment with GSH for 4 months, ALT levels significantly decreased, and triglycerides, non-esterified fatty acids, and ferritin levels also decreased demonstrating the potential therapeutic effects of oral administration of GSH in practical dose for patients with NAFLD [93]

It all just depends on how we view this natural process of free radical production and its consequences